Shipments of ammonium perchlorate are expected to reach Iran in coming months and could fuel hundreds of ballistic missiles, the people said. Some of the material would likely be sent to militias in ...

HSBC upgraded Dr. Reddy’s Laboratories Limited (NYSE:RDY) from Buy to Hold, raising the price target to INR1,445 from ...

Fintel reports that on June 5, 2025, HSBC upgraded their outlook for Dr. Reddy's Laboratories Limited - Depositary Receipt () ...

HSBC upgraded Dr Reddy’s Laboratories to Buy from Hold and raised its target price to INR 1445, citing expectations that sales of semaglutide, a generic version of Novo Nordisk’s blockbuster ...

Dr. Reddy’s Laboratories shares rose 4% to Rs 1303.45 against previous close of Rs 1252.15 on BSE. Market cap of the firm ...

Dr Reddy's Lab shares jumped 4% on June 5, making it the top gainer on the Nifty 50. This surge followed the announcement of ...

Shares of Dr. Reddy’s Laboratories jumped 4 per cent to Rs 1,303, positioning it among the leading gainers on the Nifty 50.

Dr Reddy's announced a strategic partnership with Alvotech to develop a biosimilar to Keytruda, a top-selling cancer therapy ...

Dr. Reddy's had announced that it has signed a collaboration agreement with Alvotech to co-develop the biosimilar candidate ...

TransAlta's new buyback program, following last year’s successful repurchase, could support share prices. Read more on TA:CA ...

The US is at a low risk of an imminent debt crisis — but high risk in the long term, billionaire investor Ray Dalio writes in a new book.

The Indian banking regulator is signalling possible rule changes ahead that would let foreigners own more of India's banks, ...